id	sid	eid	entity	type
dpc-2121	2	1	2021;11(4):e2021145	CARDINAL
dpc-2121	2	2	1	CARDINAL
dpc-2121	2	3	miguel nogueira1	PERSON
dpc-2121	2	4	1	CARDINAL
dpc-2121	2	5	porto	GPE
dpc-2121	2	6	porto	GPE
dpc-2121	2	7	portugal	GPE
dpc-2121	2	8	2	CARDINAL
dpc-2121	2	9	instituto de ciências biomédicas abel salazar	ORG
dpc-2121	2	10	university of porto	ORG
dpc-2121	2	11	porto	GPE
dpc-2121	2	12	portugal key	ORG
dpc-2121	2	13	nogueira m	PERSON
dpc-2121	2	14	t. janus	GPE
dpc-2121	4	1	2021;11(4):e2021145	CARDINAL
dpc-2121	4	2	october 15	DATE
dpc-2121	4	3	2021	CARDINAL
dpc-2121	4	4	october	DATE
dpc-2121	4	5	2021	CARDINAL
dpc-2121	5	1	2021	CARDINAL
dpc-2121	8	1	miguel nogueira	PERSON
dpc-2121	8	2	leo pharma	PERSON
dpc-2121	9	1	tiago torres	PERSON
dpc-2121	9	2	amgen	ORG
dpc-2121	9	3	boehringer ingelheim	ORG
dpc-2121	9	4	bristol-myers squibb	ORG
dpc-2121	9	5	janssen	GPE
dpc-2121	9	6	leo pharma	PERSON
dpc-2121	9	7	msd	ORG
dpc-2121	9	8	novartis	ORG
dpc-2121	9	9	samsung-bioepis	ORG
dpc-2121	9	10	sandoz	ORG
dpc-2121	9	11	sanofi	ORG
dpc-2121	11	1	tiago torres	PERSON
dpc-2121	11	2	porto	GPE
dpc-2121	11	3	porto	GPE
dpc-2121	11	4	portugal	GPE
dpc-2121	11	5	daily	DATE
dpc-2121	12	1	the last decade	DATE
dpc-2121	13	1	th2	PERSON
dpc-2121	13	2	th17	PRODUCT
dpc-2121	13	3	th22	PRODUCT
dpc-2121	15	1	baricitinib	ORG
dpc-2121	15	2	three	CARDINAL
dpc-2121	17	1	anna balato.	PERSON
dpc-2121	19	1	anna balato	PERSON
dpc-2121	19	2	md	GPE
dpc-2121	19	3	phd	PERSON
dpc-2121	19	4	university of campania	ORG
dpc-2121	19	5	naples	GPE
dpc-2121	19	6	italy 2	ORG
dpc-2121	20	1	2021;11(4):e2021145	CARDINAL
dpc-2121	20	2	up to 20%	PERCENT
dpc-2121	20	3	1,2	CARDINAL
dpc-2121	22	1	6 years of age	DATE
dpc-2121	22	2	80%	PERCENT
dpc-2121	22	3	2–4	CARDINAL
dpc-2121	23	1	2–4	CARDINAL
dpc-2121	24	1	daily	DATE
dpc-2121	24	2	2–4	CARDINAL
dpc-2121	25	1	3	CARDINAL
dpc-2121	26	1	2,5	CARDINAL
dpc-2121	27	1	3	CARDINAL
dpc-2121	27	2	5-fold	CARDINAL
dpc-2121	27	3	one	CARDINAL
dpc-2121	27	4	2	CARDINAL
dpc-2121	28	1	the last decade	DATE
dpc-2121	28	2	2,6,7	CARDINAL
dpc-2121	30	1	first	ORDINAL
dpc-2121	30	2	6 years of age or older	DATE
dpc-2121	33	1	4,6–9	CARDINAL
dpc-2121	34	1	janus kinase	PERSON
dpc-2121	34	2	th2	PERSON
dpc-2121	34	3	th17	PRODUCT
dpc-2121	34	4	th22	PRODUCT
dpc-2121	34	5	10	CARDINAL
dpc-2121	34	6	11	CARDINAL
dpc-2121	35	1	12	CARDINAL
dpc-2121	36	1	two	CARDINAL
dpc-2121	37	1	12	CARDINAL
dpc-2121	38	1	four	CARDINAL
dpc-2121	38	2	jak1	GPE
dpc-2121	38	3	jak2	GPE
dpc-2121	38	4	jak3	ORG
dpc-2121	38	5	tyk2	GPE
dpc-2121	38	6	seven	CARDINAL
dpc-2121	38	7	stat1	PRODUCT
dpc-2121	38	8	stat2	ORG
dpc-2121	38	9	stat3	ORG
dpc-2121	38	10	stat6	PERSON
dpc-2121	39	1	12	CARDINAL
dpc-2121	40	1	jak1	PERSON
dpc-2121	40	2	jak3	PERSON
dpc-2121	40	3	10,11	CARDINAL
dpc-2121	41	1	jak1	PERSON
dpc-2121	42	1	11,13	CARDINAL
dpc-2121	43	1	stat6	PERSON
dpc-2121	43	2	jak1	PERSON
dpc-2121	43	3	jak3	PERSON
dpc-2121	43	4	10,11,14,15	CARDINAL
dpc-2121	44	1	jak2	GPE
dpc-2121	44	2	tyk2	GPE
dpc-2121	44	3	stat4	PERSON
dpc-2121	44	4	10,11	CARDINAL
dpc-2121	45	1	the last decade	DATE
dpc-2121	45	2	10,11,16	CARDINAL
dpc-2121	51	1	2021;11(4):e2021145 3	DATE
dpc-2121	51	2	1	CARDINAL
dpc-2121	52	1	baricitinib baricitinib	PERSON
dpc-2121	52	2	jak1	PERSON
dpc-2121	52	3	jak2	GPE
dpc-2121	52	4	10,11	CARDINAL
dpc-2121	53	1	the european medicines	ORG
dpc-2121	53	2	ema	ORG
dpc-2121	53	3	table1	PERSON
dpc-2121	55	1	jak	GPE
dpc-2121	55	2	jak1	GPE
dpc-2121	55	3	jak2 breezead1	PERSON
dpc-2121	56	1	18	CARDINAL
dpc-2121	56	2	624 16	CARDINAL
dpc-2121	56	3	0/1	CARDINAL
dpc-2121	56	4	16	CARDINAL
dpc-2121	56	5	2mg	QUANTITY
dpc-2121	56	6	11.4%	PERCENT
dpc-2121	56	7	4mg	TIME
dpc-2121	56	8	16.8%	PERCENT
dpc-2121	56	9	4.8%	PERCENT
dpc-2121	56	10	cpk	GPE
dpc-2121	56	11	breezead2	PERSON
dpc-2121	57	1	18	CARDINAL
dpc-2121	57	2	615 16	CARDINAL
dpc-2121	57	3	0/1	CARDINAL
dpc-2121	57	4	16	CARDINAL
dpc-2121	57	5	2mg	QUANTITY
dpc-2121	57	6	10.6%	PERCENT
dpc-2121	57	7	4mg	TIME
dpc-2121	57	8	13.8%	PERCENT
dpc-2121	57	9	4.5%	PERCENT
dpc-2121	57	10	cpk	GPE
dpc-2121	57	11	breezead3	ORG
dpc-2121	58	1	19	CARDINAL
dpc-2121	58	2	221	CARDINAL
dpc-2121	58	3	16	CARDINAL
dpc-2121	58	4	52	CARDINAL
dpc-2121	58	5	0/1	CARDINAL
dpc-2121	58	6	week 16, 36	DATE
dpc-2121	58	7	52	CARDINAL
dpc-2121	58	8	week 52	DATE
dpc-2121	58	9	2mg	QUANTITY
dpc-2121	58	10	59.3%	PERCENT
dpc-2121	58	11	4mg	TIME
dpc-2121	58	12	47.1%	PERCENT
dpc-2121	59	1	20	CARDINAL
dpc-2121	59	2	463 16	CARDINAL
dpc-2121	59	3	wks easi75	PERSON
dpc-2121	59	4	16	CARDINAL
dpc-2121	59	5	2mg+tcs	CARDINAL
dpc-2121	59	6	27.6%	PERCENT
dpc-2121	59	7	4mg+tcs	CARDINAL
dpc-2121	59	8	31.5%	PERCENT
dpc-2121	59	9	17.2%	PERCENT
dpc-2121	59	10	breezead7	GPE
dpc-2121	60	1	21	CARDINAL
dpc-2121	60	2	329 16	CARDINAL
dpc-2121	60	3	0/1	CARDINAL
dpc-2121	60	4	16	CARDINAL
dpc-2121	60	5	2mg+tcs	CARDINAL
dpc-2121	60	6	24.0%	PERCENT
dpc-2121	60	7	4mg+tcs	CARDINAL
dpc-2121	60	8	31.0%	PERCENT
dpc-2121	60	9	15.0%	PERCENT
dpc-2121	60	10	jak1	PERSON
dpc-2121	60	11	1	CARDINAL
dpc-2121	60	12	24	CARDINAL
dpc-2121	60	13	847 16	CARDINAL
dpc-2121	60	14	69.6%	PERCENT
dpc-2121	60	15	79.9%	PERCENT
dpc-2121	60	16	16.3%	PERCENT
dpc-2121	60	17	0/1	CARDINAL
dpc-2121	60	18	week 16	DATE
dpc-2121	60	19	48.1%	PERCENT
dpc-2121	60	20	62.0%	PERCENT
dpc-2121	60	21	8.4%	PERCENT
dpc-2121	60	22	2	CARDINAL
dpc-2121	60	23	24	CARDINAL
dpc-2121	60	24	836 16	CARDINAL
dpc-2121	60	25	60.1%	PERCENT
dpc-2121	60	26	72.9%	PERCENT
dpc-2121	60	27	13.3%	PERCENT
dpc-2121	60	28	0/1	CARDINAL
dpc-2121	60	29	week 16	DATE
dpc-2121	60	30	38.8%	PERCENT
dpc-2121	60	31	52.0%	PERCENT
dpc-2121	60	32	4.7%	PERCENT
dpc-2121	61	1	25,26	CARDINAL
dpc-2121	61	2	901 52	CARDINAL
dpc-2121	61	3	wks easi75	PERSON
dpc-2121	61	4	16	CARDINAL
dpc-2121	61	5	64.6%	PERCENT
dpc-2121	61	6	30mg+tcs	ORG
dpc-2121	61	7	77.1%	PERCENT
dpc-2121	61	8	26.4%	PERCENT
dpc-2121	61	9	0/1	CARDINAL
dpc-2121	61	10	16	CARDINAL
dpc-2121	61	11	39.6%	PERCENT
dpc-2121	61	12	30mg+tcs	ORG
dpc-2121	61	13	58.6%	PERCENT
dpc-2121	61	14	10.9%	PERCENT
dpc-2121	61	15	27	CARDINAL
dpc-2121	61	16	wks easi75	PERSON
dpc-2121	61	17	71.0%	PERCENT
dpc-2121	61	18	61.1%	PERCENT
dpc-2121	61	19	table1	GPE
dpc-2121	61	20	4	CARDINAL
dpc-2121	62	1	2021;11(4):e2021145	CARDINAL
dpc-2121	62	2	jak	GPE
dpc-2121	62	3	jak1	GPE
dpc-2121	63	1	28	CARDINAL
dpc-2121	63	2	387 12	CARDINAL
dpc-2121	63	3	wks easi75	PERSON
dpc-2121	63	4	12 abrocitinib 100mg	QUANTITY
dpc-2121	63	5	40.0%	PERCENT
dpc-2121	63	6	63.0%	PERCENT
dpc-2121	63	7	12.0%	PERCENT
dpc-2121	63	8	iga	ORG
dpc-2121	63	9	0/1	PRODUCT
dpc-2121	63	10	12 abrocitinib 100mg	QUANTITY
dpc-2121	63	11	24.0%	PERCENT
dpc-2121	63	12	44.0%	PERCENT
dpc-2121	63	13	8.0%	PERCENT
dpc-2121	63	14	29	CARDINAL
dpc-2121	63	15	391 12	CARDINAL
dpc-2121	63	16	wks easi75	PERSON
dpc-2121	63	17	12 abrocitinib 100mg	QUANTITY
dpc-2121	63	18	45.0%	PERCENT
dpc-2121	63	19	61.0%	PERCENT
dpc-2121	63	20	10.0%	PERCENT
dpc-2121	63	21	iga	ORG
dpc-2121	63	22	0/1	PRODUCT
dpc-2121	63	23	12 abrocitinib 100mg	QUANTITY
dpc-2121	63	24	28.0%	PERCENT
dpc-2121	63	25	38.0%	PERCENT
dpc-2121	63	26	9.0%	PERCENT
dpc-2121	63	27	nasopharyngitis jade	GPE
dpc-2121	63	28	30	CARDINAL
dpc-2121	63	29	838 16	CARDINAL
dpc-2121	63	30	wks easi75	PERSON
dpc-2121	63	31	week 12	DATE
dpc-2121	64	1	58.7%	PERCENT
dpc-2121	64	2	70.3%	PERCENT
dpc-2121	64	3	58.1%	PERCENT
dpc-2121	64	4	27.1%	PERCENT
dpc-2121	64	5	iga	ORG
dpc-2121	64	6	0/1	PRODUCT
dpc-2121	64	7	week 12	DATE
dpc-2121	64	8	36.6%	PERCENT
dpc-2121	64	9	48.4%	PERCENT
dpc-2121	64	10	36.5%	PERCENT
dpc-2121	64	11	14.0%	PERCENT
dpc-2121	64	12	thrombocytopenia jade	GPE
dpc-2121	65	1	31	CARDINAL
dpc-2121	65	2	1233	CARDINAL
dpc-2121	65	3	798	CARDINAL
dpc-2121	65	4	12-week	DATE
dpc-2121	65	5	52	CARDINAL
dpc-2121	65	6	easi50	DATE
dpc-2121	65	7	iga	ORG
dpc-2121	65	8	52 abrocitinib 100mg	QUANTITY
dpc-2121	65	9	57.4%	PERCENT
dpc-2121	65	10	81.1%	PERCENT
dpc-2121	65	11	19.1%	PERCENT
dpc-2121	65	12	cpk jade	GPE
dpc-2121	66	1	32	CARDINAL
dpc-2121	66	2	285 12	DATE
dpc-2121	66	3	12	CARDINAL
dpc-2121	66	4	68.5%	PERCENT
dpc-2121	66	5	72.0%	PERCENT
dpc-2121	66	6	41.5%	PERCENT
dpc-2121	66	7	iga	ORG
dpc-2121	66	8	0/1	PRODUCT
dpc-2121	66	9	12	CARDINAL
dpc-2121	66	10	41.6%	PERCENT
dpc-2121	66	11	46.2%	PERCENT
dpc-2121	66	12	24.5%	PERCENT
dpc-2121	66	13	easi	ORG
dpc-2121	66	14	easi-50	DATE
dpc-2121	66	15	50%	PERCENT
dpc-2121	66	16	easi	ORG
dpc-2121	66	17	easi-75	DATE
dpc-2121	66	18	75%	PERCENT
dpc-2121	66	19	easi	ORG
dpc-2121	66	20	iga	ORG
dpc-2121	66	21	0/1	PRODUCT
dpc-2121	66	22	0	CARDINAL
dpc-2121	66	23	1	CARDINAL
dpc-2121	66	24	jak = janus kinase	PERSON
dpc-2121	66	25	0/1	CARDINAL
dpc-2121	66	26	0	CARDINAL
dpc-2121	66	27	1	CARDINAL
dpc-2121	66	28	weeks	DATE
dpc-2121	66	29	table1	PERSON
dpc-2121	68	1	fda	ORG
dpc-2121	69	1	17	CARDINAL
dpc-2121	70	1	4 mg	QUANTITY
dpc-2121	70	2	daily	DATE
dpc-2121	71	1	half	CARDINAL
dpc-2121	71	2	75 years or older	DATE
dpc-2121	71	3	17	CARDINAL
dpc-2121	72	1	1 mg	QUANTITY
dpc-2121	73	1	two	CARDINAL
dpc-2121	73	2	16-week	DATE
dpc-2121	73	3	2 mg	QUANTITY
dpc-2121	73	4	4 mg	QUANTITY
dpc-2121	73	5	18	CARDINAL
dpc-2121	74	1	0	CARDINAL
dpc-2121	74	2	1	CARDINAL
dpc-2121	74	3	2 mg	QUANTITY
dpc-2121	74	4	4 mg	QUANTITY
dpc-2121	74	5	daily	DATE
dpc-2121	74	6	624	CARDINAL
dpc-2121	74	7	2	CARDINAL
dpc-2121	74	8	11.4 %	PERCENT
dpc-2121	74	9	16.8 %	PERCENT
dpc-2121	74	10	4.8 %	PERCENT
dpc-2121	74	11	0.05	CARDINAL
dpc-2121	74	12	0.001	CARDINAL
dpc-2121	74	13	615	CARDINAL
dpc-2121	74	14	2	CARDINAL
dpc-2121	74	15	10.6 %	PERCENT
dpc-2121	74	16	13.8 %	PERCENT
dpc-2121	74	17	4.5 %	PERCENT
dpc-2121	74	18	0.05	CARDINAL
dpc-2121	74	19	0.001	CARDINAL
dpc-2121	75	1	secondary	ORDINAL
dpc-2121	75	2	4 mg	TIME
dpc-2121	77	1	2021;11(4):e2021145 5 night	TIME
dpc-2121	77	2	week 1	DATE
dpc-2121	77	3	week 1	DATE
dpc-2121	77	4	4 mg	TIME
dpc-2121	77	5	2 mg	QUANTITY
dpc-2121	77	6	week 2	DATE
dpc-2121	77	7	first	ORDINAL
dpc-2121	78	1	54 to 58 %	PERCENT
dpc-2121	79	1	cpk	GPE
dpc-2121	80	1	2	CARDINAL
dpc-2121	80	2	3.3 %	PERCENT
dpc-2121	80	3	7.2 %	PERCENT
dpc-2121	80	4	1.2 %	PERCENT
dpc-2121	82	1	16-week	DATE
dpc-2121	82	2	4 mg	QUANTITY
dpc-2121	82	3	2 mg	QUANTITY
dpc-2121	83	1	19	CARDINAL
dpc-2121	84	1	2 mg	QUANTITY
dpc-2121	84	2	4 mg	TIME
dpc-2121	84	3	0	CARDINAL
dpc-2121	84	4	1	CARDINAL
dpc-2121	84	5	46.3 %	PERCENT
dpc-2121	84	6	45.7 %	PERCENT
dpc-2121	85	1	week 68	DATE
dpc-2121	85	2	59.3 %	PERCENT
dpc-2121	85	3	47.1 %	PERCENT
dpc-2121	86	1	2 mg	QUANTITY
dpc-2121	86	2	4 mg	QUANTITY
dpc-2121	86	3	two	CARDINAL
dpc-2121	87	1	20	CARDINAL
dpc-2121	87	2	21	CARDINAL
dpc-2121	88	1	75 %	PERCENT
dpc-2121	88	2	easi	ORG
dpc-2121	88	3	0/1	CARDINAL
dpc-2121	88	4	week 16	DATE
dpc-2121	89	1	31.5 %	PERCENT
dpc-2121	89	2	4 mg	TIME
dpc-2121	89	3	easi75	PERSON
dpc-2121	89	4	2	CARDINAL
dpc-2121	89	5	27.6 %	PERCENT
dpc-2121	89	6	17.2 %	PERCENT
dpc-2121	89	7	31.0 %	PERCENT
dpc-2121	89	8	0/1	CARDINAL
dpc-2121	89	9	2	CARDINAL
dpc-2121	89	10	24.0 %	PERCENT
dpc-2121	89	11	15.0 %	PERCENT
dpc-2121	90	1	4 mg	TIME
dpc-2121	90	2	day 4	DATE
dpc-2121	92	1	4 mg	TIME
dpc-2121	94	1	22	CARDINAL
dpc-2121	95	1	2 mg	QUANTITY
dpc-2121	95	2	4 mg	QUANTITY
dpc-2121	95	3	week 2	DATE
dpc-2121	96	1	jak1	PERSON
dpc-2121	97	1	23	CARDINAL
dpc-2121	98	1	ema	ORG
dpc-2121	98	2	12 years or older	DATE
dpc-2121	98	3	23	CARDINAL
dpc-2121	99	1	fda	ORG
dpc-2121	100	1	15 mg	QUANTITY
dpc-2121	100	2	30 mg	QUANTITY
dpc-2121	100	3	23	CARDINAL
dpc-2121	101	1	two	CARDINAL
dpc-2121	101	2	16-week	DATE
dpc-2121	101	3	1	CARDINAL
dpc-2121	101	4	2	CARDINAL
dpc-2121	101	5	12 to 75 years	DATE
dpc-2121	101	6	24	CARDINAL
dpc-2121	102	1	847	CARDINAL
dpc-2121	102	2	1	CARDINAL
dpc-2121	102	3	836	CARDINAL
dpc-2121	102	4	2	CARDINAL
dpc-2121	102	5	1:1:1	CARDINAL
dpc-2121	102	6	15	CARDINAL
dpc-2121	103	1	week 16	DATE
dpc-2121	103	2	0/1	CARDINAL
dpc-2121	103	3	1	CARDINAL
dpc-2121	103	4	69.6 %	PERCENT
dpc-2121	103	5	30	CARDINAL
dpc-2121	103	6	79.9 %	PERCENT
dpc-2121	103	7	16.3 %	PERCENT
dpc-2121	103	8	0.0001	CARDINAL
dpc-2121	103	9	0/1	CARDINAL
dpc-2121	103	10	15	CARDINAL
dpc-2121	103	11	48.1 %	PERCENT
dpc-2121	103	12	30	CARDINAL
dpc-2121	103	13	62.0 %	PERCENT
dpc-2121	103	14	8.4 %	PERCENT
dpc-2121	103	15	0.0001	CARDINAL
dpc-2121	103	16	2	CARDINAL
dpc-2121	103	17	15	CARDINAL
dpc-2121	103	18	60.1 %	PERCENT
dpc-2121	103	19	30	CARDINAL
dpc-2121	103	20	72.9 %	PERCENT
dpc-2121	103	21	13.3 %	PERCENT
dpc-2121	103	22	0.0001	CARDINAL
dpc-2121	103	23	0/1	CARDINAL
dpc-2121	103	24	15	CARDINAL
dpc-2121	103	25	38.8 %	PERCENT
dpc-2121	103	26	30	CARDINAL
dpc-2121	103	27	52.0 %	PERCENT
dpc-2121	103	28	4.7 %	PERCENT
dpc-2121	103	29	0.0001	CARDINAL
dpc-2121	104	1	week 16	DATE
dpc-2121	107	1	2 %	PERCENT
dpc-2121	108	1	52-week	DATE
dpc-2121	108	2	12 to 75 years old	DATE
dpc-2121	108	3	25,26	CARDINAL
dpc-2121	109	1	1:1:1	CARDINAL
dpc-2121	109	2	901	CARDINAL
dpc-2121	109	3	15	CARDINAL
dpc-2121	109	4	25,26	CARDINAL
dpc-2121	110	1	week 16	DATE
dpc-2121	110	2	0/1	CARDINAL
dpc-2121	110	3	two	CARDINAL
dpc-2121	110	4	64.6 %	PERCENT
dpc-2121	110	5	30	CARDINAL
dpc-2121	110	6	77.1 %	PERCENT
dpc-2121	110	7	26.4 %	PERCENT
dpc-2121	110	8	0.0001	CARDINAL
dpc-2121	110	9	0/1	CARDINAL
dpc-2121	110	10	15	CARDINAL
dpc-2121	110	11	39.6 %	PERCENT
dpc-2121	110	12	58.6 %	PERCENT
dpc-2121	110	13	10.9 %	PERCENT
dpc-2121	110	14	0.0001	CARDINAL
dpc-2121	110	15	25	CARDINAL
dpc-2121	111	1	6	CARDINAL
dpc-2121	112	1	2021;11(4):e2021145	CARDINAL
dpc-2121	112	2	as early as week 2	DATE
dpc-2121	112	3	25	CARDINAL
dpc-2121	113	1	1 to 2 %	PERCENT
dpc-2121	113	2	25	CARDINAL
dpc-2121	114	1	week 16	DATE
dpc-2121	115	1	25	CARDINAL
dpc-2121	116	1	week 52	DATE
dpc-2121	116	2	26	CARDINAL
dpc-2121	117	1	26	CARDINAL
dpc-2121	118	1	24-week	DATE
dpc-2121	119	1	27	CARDINAL
dpc-2121	120	1	692	CARDINAL
dpc-2121	120	2	1:1	CARDINAL
dpc-2121	120	3	30	CARDINAL
dpc-2121	120	4	daily	DATE
dpc-2121	120	5	300 mg	QUANTITY
dpc-2121	120	6	600 mg	QUANTITY
dpc-2121	121	1	week 16	DATE
dpc-2121	121	2	71.0 %	PERCENT
dpc-2121	121	3	61.1 %	PERCENT
dpc-2121	121	4	0.006	CARDINAL
dpc-2121	122	1	43.7 %	PERCENT
dpc-2121	122	2	week 2	DATE
dpc-2121	122	3	17.4 %	PERCENT
dpc-2121	125	1	one	CARDINAL
dpc-2121	126	1	abrocitinib abrocitinib	PERSON
dpc-2121	126	2	jak1	PERSON
dpc-2121	126	3	fda	ORG
dpc-2121	126	4	ema	ORG
dpc-2121	127	1	fda	ORG
dpc-2121	128	1	two	CARDINAL
dpc-2121	128	2	12-week	DATE
dpc-2121	128	3	100 mg	QUANTITY
dpc-2121	128	4	200	CARDINAL
dpc-2121	128	5	daily	DATE
dpc-2121	128	6	778	CARDINAL
dpc-2121	128	7	12 years or older	DATE
dpc-2121	129	1	week 12	DATE
dpc-2121	129	2	iga	ORG
dpc-2121	129	3	0	CARDINAL
dpc-2121	129	4	1	CARDINAL
dpc-2121	130	1	abrocitinib 100	PERSON
dpc-2121	130	2	40 %	PERCENT
dpc-2121	130	3	63 %	PERCENT
dpc-2121	130	4	12 %	PERCENT
dpc-2121	130	5	0.0001	CARDINAL
dpc-2121	130	6	iga	ORG
dpc-2121	130	7	0/1	CARDINAL
dpc-2121	130	8	abrocitinib 100	PERSON
dpc-2121	130	9	24 %	PERCENT
dpc-2121	130	10	44 %	PERCENT
dpc-2121	130	11	8 %	PERCENT
dpc-2121	130	12	0.0037	CARDINAL
dpc-2121	130	13	0.0001	CARDINAL
dpc-2121	130	14	75	CARDINAL
dpc-2121	130	15	45 %	PERCENT
dpc-2121	130	16	61 %	PERCENT
dpc-2121	130	17	10 %	PERCENT
dpc-2121	130	18	0.001	CARDINAL
dpc-2121	130	19	iga	ORG
dpc-2121	130	20	0/1	CARDINAL
dpc-2121	130	21	abrocitinib 100 mg	PERSON
dpc-2121	130	22	28 %	PERCENT
dpc-2121	130	23	38 %	PERCENT
dpc-2121	130	24	9 %	PERCENT
dpc-2121	130	25	0.001	CARDINAL
dpc-2121	131	1	69 78 %	PERCENT
dpc-2121	131	2	57 %	PERCENT
dpc-2121	131	3	63 66 %	PERCENT
dpc-2121	131	4	42 %	PERCENT
dpc-2121	133	1	abrocitinib	PERSON
dpc-2121	135	1	16 weeks	DATE
dpc-2121	135	2	nct03422822	GPE
dpc-2121	135	3	92 weeks	DATE
dpc-2121	135	4	100 mg	QUANTITY
dpc-2121	135	5	200 mg	QUANTITY
dpc-2121	136	1	16-week	DATE
dpc-2121	136	2	838	CARDINAL
dpc-2121	136	3	100 mg	QUANTITY
dpc-2121	136	4	200 mg	QUANTITY
dpc-2121	136	5	300 mg	QUANTITY
dpc-2121	136	6	600 mg	QUANTITY
dpc-2121	136	7	30	CARDINAL
dpc-2121	138	1	easi75	PERSON
dpc-2121	138	2	58.7 %	PERCENT
dpc-2121	138	3	70.3 %	PERCENT
dpc-2121	138	4	abrocitinib 200 mg	LAW
dpc-2121	138	5	58.1 %	PERCENT
dpc-2121	138	6	27.1 %	PERCENT
dpc-2121	139	1	iga	ORG
dpc-2121	139	2	0/1	CARDINAL
dpc-2121	139	3	36.6 %	PERCENT
dpc-2121	139	4	48.4 %	PERCENT
dpc-2121	139	5	36.5 %	PERCENT
dpc-2121	139	6	14.0 %	PERCENT
dpc-2121	139	7	0.001	CARDINAL
dpc-2121	140	1	abrocitinib 200 mg	PERSON
dpc-2121	140	2	week 2	DATE
dpc-2121	141	1	week 16	DATE
dpc-2121	141	2	one	CARDINAL
dpc-2121	142	1	2	CARDINAL
dpc-2121	142	2	one	CARDINAL
dpc-2121	145	1	52-week	DATE
dpc-2121	145	2	12 years or	DATE
dpc-2121	145	3	iga	ORG
dpc-2121	145	4	0/1	CARDINAL
dpc-2121	145	5	12-week	DATE
dpc-2121	145	6	daily	DATE
dpc-2121	145	7	100 mg	QUANTITY
dpc-2121	145	8	200 mg	QUANTITY
dpc-2121	145	9	40 weeks	DATE
dpc-2121	146	1	31	CARDINAL
dpc-2121	147	1	1233	CARDINAL
dpc-2121	147	2	week 0	DATE
dpc-2121	147	3	798	CARDINAL
dpc-2121	147	4	64.7 %	PERCENT
dpc-2121	147	5	12-week	DATE
dpc-2121	148	1	easi50	DATE
dpc-2121	148	2	iga	ORG
dpc-2121	148	3	57.4 %	PERCENT
dpc-2121	148	4	81.1 %	PERCENT
dpc-2121	148	5	abrocitinib 200 mg	LAW
dpc-2121	148	6	19.1 %	PERCENT
dpc-2121	148	7	abrocitinib 200 mg	PRODUCT
dpc-2121	149	1	2021;11(4):e2021145 7	DATE
dpc-2121	150	1	54.0 %	PERCENT
dpc-2121	150	2	63.2 %	PERCENT
dpc-2121	150	3	1.9 %	PERCENT
dpc-2121	150	4	6.0 %	PERCENT
dpc-2121	151	1	285	CARDINAL
dpc-2121	151	2	12 to 17 years	DATE
dpc-2121	151	3	12-week	DATE
dpc-2121	151	4	daily	DATE
dpc-2121	151	5	abrocitinib 200 mg	PRODUCT
dpc-2121	151	6	32	CARDINAL
dpc-2121	152	1	easi75	PERSON
dpc-2121	152	2	iga	ORG
dpc-2121	152	3	0/1	CARDINAL
dpc-2121	152	4	abrocitinib 100	PERSON
dpc-2121	152	5	68.5 %	PERCENT
dpc-2121	152	6	72.0 %	PERCENT
dpc-2121	152	7	41.5 %	PERCENT
dpc-2121	152	8	0.05	CARDINAL
dpc-2121	152	9	iga	ORG
dpc-2121	152	10	0/1	CARDINAL
dpc-2121	152	11	abrocitinib 100 mg	PERSON
dpc-2121	152	12	41.6 %	PERCENT
dpc-2121	152	13	46.2 %	PERCENT
dpc-2121	152	14	24.5 %	PERCENT
dpc-2121	152	15	0.05	CARDINAL
dpc-2121	153	1	52.0 %	PERCENT
dpc-2121	153	2	63.0 %	PERCENT
dpc-2121	154	1	1.1 %	PERCENT
dpc-2121	157	1	daily	DATE
dpc-2121	158	1	just 1 to 2 weeks	CARDINAL
dpc-2121	160	1	fda	ORG
dpc-2121	160	2	ema	ORG
dpc-2121	164	1	10,11	CARDINAL
dpc-2121	165	1	jak1	PERSON
dpc-2121	165	2	jak2	ORG
dpc-2121	165	3	jak2	FAC
dpc-2121	165	4	10,11	CARDINAL
dpc-2121	166	1	jak1	PERSON
dpc-2121	166	2	jak1	PERSON
dpc-2121	167	1	10,11	CARDINAL
dpc-2121	168	1	the last decade	DATE
dpc-2121	169	1	dupilumab	PERSON
dpc-2121	169	2	first	ORDINAL
dpc-2121	169	3	the recent years	DATE
dpc-2121	170	1	33	CARDINAL
dpc-2121	178	1	1	CARDINAL
dpc-2121	179	1	tsai h-r	PERSON
dpc-2121	179	2	j-w	ORG
dpc-2121	179	3	chen l-y	PERSON
dpc-2121	179	4	chen t-l.	PERSON
dpc-2121	180	1	j pers med	PERSON
dpc-2121	182	1	33917069	CARDINAL
dpc-2121	184	1	2	CARDINAL
dpc-2121	184	2	weidinger s	PERSON
dpc-2121	184	3	beck la	PERSON
dpc-2121	184	4	t,	GPE
dpc-2121	184	5	kabashima k	FAC
dpc-2121	184	6	irvine	GPE
dpc-2121	186	1	nat rev dis	PERSON
dpc-2121	187	1	2018;4(1):1	CARDINAL
dpc-2121	188	1	doi:10.1038	ORG
dpc-2121	188	2	0001-z. pmid: 29930242	DATE
dpc-2121	189	1	3	CARDINAL
dpc-2121	189	2	johns ne	PERSON
dpc-2121	189	3	williams hc	PERSON
dpc-2121	190	1	2010	DATE
dpc-2121	192	1	2014;134(6):1534	CARDINAL
dpc-2121	194	1	pmid	PERSON
dpc-2121	194	2	24166134	DATE
dpc-2121	194	3	8	CARDINAL
dpc-2121	195	1	2021;11(4):e2021145 4	DATE
dpc-2121	196	1	cartron a	ORG
dpc-2121	196	2	nguyen t	PERSON
dpc-2121	196	3	roh y	PERSON
dpc-2121	196	4	kwatra m	ORG
dpc-2121	196	5	kwatra s. janus kinase	PERSON
dpc-2121	197	1	clin exp	ORG
dpc-2121	198	1	2021;46(5):820-824	CARDINAL
dpc-2121	199	1	ced.14567	PRODUCT
dpc-2121	200	1	33484582	DATE
dpc-2121	201	1	kim j	PERSON
dpc-2121	201	2	kim	PERSON
dpc-2121	201	3	leung dym.	PERSON
dpc-2121	203	1	2019;40(2):84-92	CARDINAL
dpc-2121	203	2	aap.2019.40.4202	GPE
dpc-2121	204	1	30819278	DATE
dpc-2121	206	1	6	CARDINAL
dpc-2121	206	2	ferreira eo	PERSON
dpc-2121	209	1	31493365	DATE
dpc-2121	210	1	7	CARDINAL
dpc-2121	210	2	dattola	PERSON
dpc-2121	210	3	silvestri m	PERSON
dpc-2121	213	1	2019;32(2):e12787	CARDINAL
dpc-2121	214	1	doi:10.1111/dth.12787	ORG
dpc-2121	215	1	30548724	DATE
dpc-2121	216	1	8	CARDINAL
dpc-2121	217	1	thyssen jp	PERSON
dpc-2121	217	2	weidinger s	ORG
dpc-2121	217	3	w. biologics	PERSON
dpc-2121	218	1	clin immunol	PERSON
dpc-2121	219	1	2021;9(3):1053-1065	CARDINAL
dpc-2121	220	1	doi:10.1016	GPE
dpc-2121	220	2	j. jaip.2020.11.034	PERSON
dpc-2121	221	1	33685604	DATE
dpc-2121	222	1	9	CARDINAL
dpc-2121	222	2	european medicines	ORG
dpc-2121	225	1	2021	CARDINAL
dpc-2121	226	1	july 27, 2021	DATE
dpc-2121	227	1	10	CARDINAL
dpc-2121	227	2	rodrigues ma	PERSON
dpc-2121	227	3	t. jak	ORG
dpc-2121	228	1	j dermatolog	PERSON
dpc-2121	229	1	2020;31(1):33-40	CARDINAL
dpc-2121	231	1	30703333	CARDINAL
dpc-2121	232	1	11	CARDINAL
dpc-2121	233	1	e. jak	PERSON
dpc-2121	234	1	j clin	PERSON
dpc-2121	235	1	2019;20(2):181-192	CARDINAL
dpc-2121	236	1	30536048	CARDINAL
dpc-2121	237	1	12	CARDINAL
dpc-2121	238	1	harrison da	PERSON
dpc-2121	241	1	2012;4(3):a011205	CARDINAL
dpc-2121	243	1	pmid	PERSON
dpc-2121	243	2	22383755	CARDINAL
dpc-2121	245	1	13	CARDINAL
dpc-2121	246	1	mack	PERSON
dpc-2121	246	2	feng j	PERSON
dpc-2121	249	1	2017;171(1):217-228.e13	CARDINAL
dpc-2121	250	1	doi:10.1016/j. cell.2017.08.006.pmid: 28890086	ORG
dpc-2121	253	1	tamura k	PERSON
dpc-2121	253	2	arakawa h	ORG
dpc-2121	253	3	suzuki m	ORG
dpc-2121	253	4	first	ORDINAL
dpc-2121	254	1	clin	PERSON
dpc-2121	255	1	2001;31(10):1509-1514	CARDINAL
dpc-2121	257	1	11678849.	DATE
dpc-2121	258	1	15	CARDINAL
dpc-2121	259	1	czimmerer z	ORG
dpc-2121	259	2	daniel b	PERSON
dpc-2121	260	1	stat6	PERSON
dpc-2121	262	1	2018;48(1):75	CARDINAL
dpc-2121	263	1	pmid	PERSON
dpc-2121	263	2	29343442	CARDINAL
dpc-2121	266	1	li	PERSON
dpc-2121	267	1	2018;9:1048	DATE
dpc-2121	268	1	doi:10.3389	ORG
dpc-2121	269	1	pmid	PERSON
dpc-2121	269	2	30386231	CARDINAL
dpc-2121	271	1	17	CARDINAL
dpc-2121	272	1	european medicines	ORG
dpc-2121	273	1	olumiant	PERSON
dpc-2121	273	2	baricitinib	ORG
dpc-2121	275	1	2021	CARDINAL
dpc-2121	276	1	july 27, 2021	DATE
dpc-2121	277	1	18	CARDINAL
dpc-2121	278	1	simpson e	PERSON
dpc-2121	278	2	lacour j-p	PERSON
dpc-2121	278	3	spelman l	GPE
dpc-2121	278	4	two	CARDINAL
dpc-2121	281	1	doi:10.1111	ORG
dpc-2121	282	1	31995838	CARDINAL
dpc-2121	283	1	19	CARDINAL
dpc-2121	284	1	silverberg ji	PERSON
dpc-2121	284	2	simpson el	GPE
dpc-2121	284	3	2	CARDINAL
dpc-2121	286	1	2021;157(6):691-699	CARDINAL
dpc-2121	287	1	doi:10.1001	GPE
dpc-2121	288	1	33978711	CARDINAL
dpc-2121	290	1	20	CARDINAL
dpc-2121	291	1	lilly	ORG
dpc-2121	292	1	lilly	ORG
dpc-2121	292	2	incyte announce	PERSON
dpc-2121	292	3	3	CARDINAL
dpc-2121	294	1	2020	DATE
dpc-2121	295	1	september 28	DATE
dpc-2121	295	2	2021	DATE
dpc-2121	296	1	21	CARDINAL
dpc-2121	297	1	reich k	PERSON
dpc-2121	297	2	kabashima k	PERSON
dpc-2121	297	3	peris k	PERSON
dpc-2121	299	1	2020;156(12):1333-1343	CARDINAL
dpc-2121	302	1	33001140	CARDINAL
dpc-2121	304	1	22	CARDINAL
dpc-2121	305	1	wollenberg	PERSON
dpc-2121	305	2	breezead7	PERSON
dpc-2121	305	3	3	CARDINAL
dpc-2121	307	1	2021;35(7):1543-1552	DATE
dpc-2121	308	1	doi:10.1111	ORG
dpc-2121	309	1	33834521	DATE
dpc-2121	311	1	23	CARDINAL
dpc-2121	312	1	european medicines	ORG
dpc-2121	315	1	2021	CARDINAL
dpc-2121	316	1	july 27, 2021	DATE
dpc-2121	317	1	24	CARDINAL
dpc-2121	318	1	teixeira hd	PERSON
dpc-2121	318	2	simpson el	GPE
dpc-2121	319	1	daily	DATE
dpc-2121	319	2	1	CARDINAL
dpc-2121	319	3	2	CARDINAL
dpc-2121	319	4	two	CARDINAL
dpc-2121	319	5	3	CARDINAL
dpc-2121	320	1	lancet	ORG
dpc-2121	321	1	2021;397(10290):2151-2168	CARDINAL
dpc-2121	322	1	doi:10.1016	GPE
dpc-2121	323	1	reich k	PERSON
dpc-2121	323	2	teixeira hd	PERSON
dpc-2121	323	3	de bruin-weller m	PERSON
dpc-2121	323	4	3	CARDINAL
dpc-2121	324	1	lancet	ORG
dpc-2121	325	1	2021;397(10290):2169-2181	CARDINAL
dpc-2121	326	1	doi:10.1016	PERSON
dpc-2121	327	1	silverberg ji	PERSON
dpc-2121	327	2	de bruin-weller m	PERSON
dpc-2121	327	3	week-52	DATE
dpc-2121	328	1	clin immunol	PERSON
dpc-2121	329	1	august 2021	DATE
dpc-2121	330	1	doi:10.1016	NORP
dpc-2121	330	2	j. jaci.2021.07.036	PERSON
dpc-2121	331	1	34403658	CARDINAL
dpc-2121	332	1	27	CARDINAL
dpc-2121	333	1	teixeira hd	PERSON
dpc-2121	333	2	simpson el	GPE
dpc-2121	337	1	doi:10.1001	GPE
dpc-2121	338	1	34347860	CARDINAL
dpc-2121	340	1	28	CARDINAL
dpc-2121	340	2	simpson el	GPE
dpc-2121	340	3	sinclair r	ORG
dpc-2121	340	4	forman s	ORG
dpc-2121	340	5	3	CARDINAL
dpc-2121	341	1	lancet	ORG
dpc-2121	342	1	2020;396(10246):255-266	CARDINAL
dpc-2121	343	1	doi:10.1016	NORP
dpc-2121	343	2	7 29	DATE
dpc-2121	344	1	silverberg ji	PERSON
dpc-2121	344	2	simpson el	GPE
dpc-2121	344	3	thyssen jp	PERSON
dpc-2121	345	1	jama derreview	PERSON
dpc-2121	346	1	2021;11(4):e2021145 9	DATE
dpc-2121	347	1	2020;156(8):863	CARDINAL
dpc-2121	348	1	doi:10.1001	GPE
dpc-2121	349	1	32492087	DATE
dpc-2121	351	1	30	CARDINAL
dpc-2121	352	1	simpson el	GPE
dpc-2121	352	2	silverberg ji	PERSON
dpc-2121	352	3	abrocitinib	PERSON
dpc-2121	354	1	2021;384(12):1101-1112	DATE
dpc-2121	357	1	31	DATE
dpc-2121	358	1	silverberg ji	PERSON
dpc-2121	358	2	lynde cw	PERSON
dpc-2121	358	3	jak1	PERSON
dpc-2121	358	4	3	CARDINAL
dpc-2121	359	1	j am	PERSON
dpc-2121	360	1	august 2021	DATE
dpc-2121	361	1	doi:10.1016	NORP
dpc-2121	361	2	j. jaad.2021.05.075	PERSON
dpc-2121	363	1	32	CARDINAL
dpc-2121	364	1	eichenfield lf	PERSON
dpc-2121	364	2	sidbury	GPE
dpc-2121	366	1	2021	CARDINAL
dpc-2121	367	1	doi:10.1001	GPE
dpc-2121	368	1	34406366	DATE
dpc-2121	370	1	33	CARDINAL
dpc-2121	371	1	seegräber m	PERSON
dpc-2121	371	2	wollenberg a. dupilumab	PERSON
dpc-2121	372	1	rev clin	PERSON
dpc-2121	373	1	2018;11(5):467-474	CARDINAL
dpc-2121	375	1	29557246	CARDINAL
dpc-2121	376	1	34	CARDINAL
dpc-2121	377	1	thyssen jp	PERSON
dpc-2121	377	2	thomsen sf	PERSON
dpc-2121	379	1	lancet	ORG
dpc-2121	380	1	2021;397(10290):21262128	CARDINAL
dpc-2121	381	1	doi:10.1016	GPE
dpc-2121	381	2	35	DATE
dpc-2121	382	1	chovatiya	GPE
dpc-2121	382	2	a. jak	PERSON
dpc-2121	383	1	j allergy clin immunol	PERSON
dpc-2121	384	1	august 2021	DATE
dpc-2121	385	1	doi:10.1016/j. jaci.2021.08.009.	ORG
dpc-2121	386	1	34437922	DATE
dpc-2121	387	1	36	CARDINAL
dpc-2121	388	1	melo	PERSON
dpc-2121	388	2	carrascosa jm	PERSON
dpc-2121	388	3	torres t. baricitinib	PERSON
dpc-2121	389	1	j dermatolog	PERSON
dpc-2121	390	1	august	DATE
dpc-2121	390	2	2021:1-10	DATE
dpc-2121	392	1	34379541	CARDINAL
dpc-2121	393	1	37	DATE
dpc-2121	394	1	singh	GPE
dpc-2121	394	2	feldman sr.	PERSON
dpc-2121	397	1	2020;9:255	CARDINAL
dpc-2121	399	1	33204661	DATE